Form D · Other Health Care

BreStem Therapeutics, Inc.

Raleigh, NC · CIK 0001723963

Offering snapshot reported Nov 24, 2021 · SEC filing

Reported sold
$3M
Offering amount: $3M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 21, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.5M$3MJul 6, 2021: $250,000.00Jul 6, 2021Nov 24, 2021: $3,000,000.00Nov 24, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$250,000 → $3,000,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 24, 2021Amendment$3,000,000$2,750,000vs Jul 6, 20213SEC filing
Jul 6, 2021Initial$250,000No comparisonNot reportedSEC filing
Nov 29, 2017Initial$50,000No comparison1SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-405341

Source: Form D, filed Nov 24, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ke Cheng Director, Executive
Weigang Wang Director
Weili Zhou Director
Dongmei Zhu Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1001 William Moore Drive
Raleigh, NC, 27606